Clinical trials in West Reading, PA

13 recruiting studies have a site in or near West Reading, PA, Pennsylvania.

Top conditions here

All conditions

Showing 13 of 13 studies

RecruitingPhase 3NCT04267848

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Sponsor: National Cancer Institute (NCI)

Allentown, PA · Altoona, PA · Beaver, PA · +1147 more sites

RecruitingPhase 3NCT06498635

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Sponsor: National Cancer Institute (NCI)

Allentown, PA · Bethlehem, PA · Bryn Mawr, PA · +278 more sites

RecruitingPhase 2NCT05554393

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

Sponsor: National Cancer Institute (NCI)

Allentown, PA · Danville, PA · Hershey, PA · +172 more sites

RecruitingPhase 2NCT06317649

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

Sponsor: National Cancer Institute (NCI)

Allentown, PA · Danville, PA · Hershey, PA · +222 more sites

RecruitingPhase not listedNCT05334069

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Sponsor: Alliance for Clinical Trials in Oncology

Allentown, PA · Bethlehem, PA · Danville, PA · +744 more sites

RecruitingPhase 3NCT05879926

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Sponsor: NRG Oncology

Allentown, PA · Bethlehem, PA · +1223 more sites

RecruitingPhase 3NCT05812807

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

Sponsor: Alliance for Clinical Trials in Oncology

Allentown, PA · Bethlehem, PA · Chambersburg, PA · +825 more sites

RecruitingPhase 3NCT06748222

E-Mindfulness Approaches for Living After Breast Cancer

Sponsor: NRG Oncology

Carlisle, PA · Chambersburg, PA · Danville, PA · +378 more sites

RecruitingPhase 3NCT06376994

Multi-Center Clean Air Randomized Controlled Trial in COPD

Sponsor: JHSPH Center for Clinical Trials

West Reading, PA · +10 more sites

RecruitingPhase not listedNCT03151629

International Registry for Men With Advanced Prostate Cancer (IRONMAN)

Sponsor: Prostate Cancer Clinical Trials Consortium

Doylestown, PA · Philadelphia, PA · +45 more sites

RecruitingPhase not listedNCT07112924

CCM OPEN HF Registry

Sponsor: Impulse Dynamics

West Reading, PA · +27 more sites

RecruitingPhase 3NCT05929768

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

Sponsor: SWOG Cancer Research Network

Allentown, PA · Bethlehem, PA · Bryn Mawr, PA · +952 more sites

RecruitingNot applicableNCT05893927

Impact of a Diabetes Education Mobile Web Application on Patients With Uncontrolled Type 2 Diabetes

Sponsor: The Reading Hospital and Medical Center

West Reading, PA

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.